BGTCF
Beijing Geekplus Technology Co., Ltd.$0.8000 +0.00 (+0.00%)
Oct 23 4:00 PM ET · prev $0.8000
Since first trade
−10.1%
from $0.8899 · Oct 8
30 days
−10.1%
from $0.8899
Range since listing
$0.8000–0.8899
−10% from high · low Oct 22
Avg volume 12D
271
Oct 22 spike 2.5K
Short interest
40.6K
−63.1%
Price
Daily candles with volume.
No data for this timeframe.
Signal stack
Where each data set points today.
- Short sellersCOVERING
Short interest −63.1% to 40.6K shares.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 13, 2026 Clinical trial readout
T-90d Trial Readout: ZT006 (Phase 2)
Trial: Efficacy and Safety of ZT006 in Overweight and Obese Participants Sponsor: Beijing QL Biophar
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 13, 2026
Trial readout
T-90d Trial Readout: ZT006 (Phase 2)
Trial: Efficacy and Safety of ZT006 in Overweight and Obese Participants Sponsor: Beijing QL Biopharmaceutical Co.,Ltd Phase: Phase 2 | Status…
Sep 12, 2026
Trial readout
T-90d Trial Readout: ZT006 (Phase 2)
Trial: Efficacy and Safety of ZT006 in Overweight and Obese Participants Sponsor: Beijing QL Biopharmaceutical Co.,Ltd Phase: Phase 2 | Status…
Jun 11, 2026
Clinical Trial
Evaluating Different Doses of Orelabrutinib in MCL
Phase 2 · COMPLETED
Jun 5, 2026
Clinical Trial
A Study of PLB1001 in Non-small Cell Lung Cancer With c-Met Dysregulation(KUNPENG)
Phase 2 · COMPLETED
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Sep 30, 202640,600
shares short
-63.1%
vs prior settlement